Prelude Therapeutics
PRLD
$3.85
Share price
-0.52%
Change (1 day)
-30.76%
Change (1 year)
Categories
EPS for Prelude Therapeutics (PRLD)
EPS in 2023 (TTM): -$2.17
According to Prelude Therapeutics's latest financial reports the company's current EPS (TTM) is -$2.17. In 2022 the company made an earnings per share (EPS) of -$2.44 a decrease over its 2021 EPS that were of -$2.42.
EPS history for Prelude Therapeutics from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$2.17 | -11.07% |
| 2022 | -$2.44 | 0.83% |
| 2021 | -$2.42 | -61.3% |
| 2020 | -$6.25 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 0.46% | 🇺🇸 USA |